Author： Bickston Stephen J Snider Kenneth R Kappus Matthew R
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.21, Iss.12, 2012-12, pp. : 1845-1849
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
New indazole derivatives as phosphodiesterase type 4 inhibitors
Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 5, 1998-05 ,pp. :
Access to resources
Recommend
Phosphodiesterase 4 inhibitors
Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 4, 1997-04 ,pp. :
Phosphodiesterase 4 inhibitors
Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 11, 1997-11 ,pp. :
Phosphodiesterase-4 Inhibitors in the Treatment of Inflammatory Lung Disease
By Spina D.
Drugs, Vol. 63, Iss. 23, 2003-01 ,pp. :